Current serotonin medications are aimed at increasing central 5-HT neurotransmission in the brain, and there are no approved indications for manipulating peripheral 5-HT, though peripheral 5-HT synthesis is being considered as a potential target for developing pharmacological agents in some disorders ( We are not aware of prior studies reporting low S-5-HT in hypothyroidism or CFS
To improve bioavailability, formulations have been developed using techniques like micronization and phospholipid complexation
Luche, H., Weber, O., Nageswara Rao, T., Blum, C
It depends on your goals, health status, and consistency
[DOI] [PubMed] [Google Scholar] 119.Global Initiative for Chronic Obstructive Lung Disease (GOLD)
It has been challenging to define an appropriate healthy microbiome composition because of inter-individual variation (Lloyd-Price et al., 2016)